Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model

Neurobiology of Disease

Volumn 41, Issue 1, 2011, Pages 219-225

  Langevin, Christelle ^a   Andréoletti, Olivier ^b   Le Dur, Annick ^a   Laude, Hubert ^a   Béringue, Vincent ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b IHAP   (France)

Author keywords

Phenotype; Prion; Scrapie; Spleen; Strain

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRION; PRIORITY JOURNAL; SCRAPIE; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, INFECTIOUS; INJECTIONS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, TRANSGENIC; NEURONS; PHENOTYPE; PROTEIN ISOFORMS; PRPSC PROTEINS; SCRAPIE; SHEEP, DOMESTIC;

EID: 78349310723     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.09.010     Document Type: Article

References (51)

1. Aguzzi A., et al. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 2007, 8:552-561.
2. Beringue V., et al. Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J. Virol. 2000, 74:5432-5440.
3. Beringue V., et al. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain 2003, 126:2065-2073.
4. Beringue V., et al. A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J. Neurosci. 2007, 27:6965-6971.
5. Beringue V., et al. Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS ONE 2008, 3:e1419.
6. Beringue V., et al. Prion agent diversity and species barrier. Vet. Res. 2008, 39:47.
7. Bessen R.A., Marsh R.F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 1994, 68:7859-7868.
8. Bolton D.C., et al. Identification of a protein that purifies with the scrapie prion. Science 1982, 218:1309-1311.
9. Brown P., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000, 55:1075-1081.
10. Bruce M.E. TSE strain variation. Br. Med. Bull. 2003, 66:99-108.
11. Bruce M.E., Dickinson A.G. Biological evidence that scrapie agent has an independent genome. J. Gen. Virol. 1987, 68(Pt 1):79-89.
12. Bruce M.E., Fraser H. Effect of route of infection on the frequency and distribution of cerebral amyloid plaques in scrapie mice. Neuropathol. Appl. Neurobiol. 1981, 7:289-298.
13. Bruce M.E., et al. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J. Gen. Virol. 1991, 72(Pt 3):595-603.
14. Cano G., et al. Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing. J. Comp. Neurol. 2001, 439:1-18.
15. Casaccia-Bonnefil P., et al. Brain regional distribution of prion protein PrP27-30 in mice stereotaxically microinjected with different strains of scrapie. J. Infect. Dis. 1993, 167:7-12.
16. Caughey B., Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 2003, 26:267-298.
17. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
18. Doh-ura K., et al. Brain injury does not modify transmissible spongiform encephalopathy caused by intraperitoneal inoculation with Fukuoka-1 strain. J. Gen. Virol. 1999, 80(Pt 6):1551-1556.
19. Dron M., et al. Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J. Biol. Chem. 2010, 285:10252-10264.
20. Ehlers B., Diringer H. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 1984, 65(Pt 8):1325-1330.
21. Fraser H. Neuropathology of scrapie: the precision of the lesions and their diversity. Slow Transmissible Diseases of the Nervous System 1979, 387-406. Academic Press, New-York. S.B. Prusiner, W.J. Hadlow (Eds.).
22. Fraser H., Dickinson A.G. The sequential development of the brain lesion of scrapie in three strains of mice. J. Comp. Pathol. 1968, 78:301-311.
23. Fraser E., et al. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies. Neuropathol. Appl. Neurobiol. 2003, 29:482-495.
24. Gibson P.H. Distributions of amyloid plaques in four regions of the brains of mice infected with scrapie by intracerebral and intraperitoneal routes of injection. Acta Neuropathol (Berl) 1986, 69:322-325.
25. Hill A.F., et al. The same prion strain causes vCJD and BSE. Nature 1997, 389(448-50):526.
26. Hill A.F., et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 2000, 97:10248-10253.
27. Jeffrey M., et al. Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies. J. Comp. Pathol. 2006, 134:171-181.
28. Kim Y.S., et al. Incubation periods and histopathological changes in mice injected stereotaxically in different brain areas with the 87V scrapie strain. Acta Neuropathol (Berl) 1990, 80:388-392.
29. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J. Comp. Pathol. 1978, 88:39-47.
30. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 1979, 89:551-562.
31. Kimberlin R.H., Walker C.A. Invasion of the CNS by scrapie agent and its spread to different parts of the brain. Virus Non-conventionnels et Affections du Systeme Nerveux Central 1983, 17-33. Masson, Paris.
32. Kimberlin R.H., Walker C.A. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 1986, 67(Pt 2):255-263.
33. Kimberlin R.H., Walker C.A. Pathogenesis of experimental scrapie. Ciba Found. Symp. 1988, 135:37-62.
34. Kimberlin R.H., Walker C.A. Transport, targeting and replication of scrapie in the CNS. Unconventional virus diseases of the central nervous system. Abbaye de Melleray, La Meilleraye-de-Bretagne 1989, 547-562. L.A. Court (Ed.).
35. Kimberlin R.H., et al. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb. Pathog. 1987, 2:405-415.
36. Krasemann S., et al. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol. Med. 1996, 2:725-734.
37. Lasmezas C.I., et al. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J. Gen. Virol. 1996, 77(Pt 7):1601-1609.
38. Le Dur A., et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc. Natl Acad. Sci. USA 2005, 102:16031-16036.
39. Mabbott N.A., MacPherson G.G. Prions and their lethal journey to the brain. Nat. Rev. Microbiol. 2006, 4:201-211.
40. Mallucci G., Collinge J. Rational targeting for prion therapeutics. Nat. Rev. Neurosci. 2005, 6:23-34.
41. McGovern G., Jeffrey M. Scrapie-specific pathology of sheep lymphoid tissues. PLoS ONE 2007, 2:e1304.
42. Prusiner S.B. Prions. Proc. Natl Acad. Sci. USA 1998, 95:13363-13383.
43. Race R., et al. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 2001, 75:10106-10112.
44. Scott J.R., Fraser H. Transport and targeting of scrapie infectivity and pathology in the optic nerve projections following intraocular infection. Prog. Clin. Biol. Res. 1989, 317:645-652.
45. Spinner D.S., et al. Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. J. Virol. 2008, 82:10701-10708.
46. Telling G.C., et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996, 274:2079-2082.
47. Tixador P., et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010, 6:e1000859.
48. Vilotte J.L., et al. Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp. J. Virol. 2001, 75:5977-5984.
49. Wadsworth J.D., et al. Review. The origin of the prion agent of kuru: molecular and biological strain typing. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3747-3753.
50. Wadsworth J.D., et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc. Natl Acad. Sci. USA 2008, 105:3885-3890.
51. Weissmann C. The state of the prion. Nat. Rev. Microbiol. 2004, 2:861-871.